April 11, 2017 09:37 AM EDT

PureTech launches an I/O startup inspired by NYU’s George Miller; SV adopts a new name

Shehla Shakoor

Managing Director

→ PureTech is launching a new biotech, this time focusing on the immuno-oncology work done by NYU’s George Miller. It’s named Nybo Therapeutics, and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

PureTech launches an I/O startup inspired by NYU’s George Miller; SV adopts a new name

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Zealand’s ‘aspirational’ mission for its amylin drug to be first-line in obesity

Viking CEO on ‘shocking’ market reaction to oral obesity data, preparing for Phase 3

Beam discloses first clinical data on base-edited sickle cell therapy, one patient death

J&J's Darzalex hits primary endpoint in Phase 3 early-stage multiple myeloma trial

Vertex makes money from sickle cell therapy Casgevy

Gene therapies don’t have to cost $4 million: New production platforms reduce development costs and risks

PureTech launch­es an I/O start­up in­spired by NYU’s George Miller; SV adopts a new name

Managing Director

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

PureTech launches an I/O startup inspired by NYU’s George Miller; SV adopts a new name